These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2346124)

  • 21. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; Yordan E; Beecham J
    Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barnes W; Ball H
    Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
    Weiss GR; Green S; Hannigan EV; Boutselis JG; Surwit EA; Wallace DL; Alberts DS
    Gynecol Oncol; 1990 Dec; 39(3):332-6. PubMed ID: 2258080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
    Arseneau J; Blessing JA; Stehman FB; McGehee R
    Invest New Drugs; 1986; 4(2):187-91. PubMed ID: 3525449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (a phase II trial of the gynecologic oncology group).
    Muss HB; Bundy BN; Homesley HD; Wilbanks G
    Invest New Drugs; 1987; 5(2):199-202. PubMed ID: 3654152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Blessing JA; Nelson BE; Johnson GA; Fowler WC; Reid GC
    Am J Clin Oncol; 1998 Dec; 21(6):591-4. PubMed ID: 9856661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.
    Wadler S; Tenteromano L; Cazenave L; Sparano JA; Greenwald ES; Rozenblit A; Kaleya R; Wiernik PH
    Cancer Chemother Pharmacol; 1994; 34(3):266-9. PubMed ID: 8004762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
    McGuire WP; Blessing JA; Hatch K; DiSaia PJ
    Invest New Drugs; 1986; 4(2):181-6. PubMed ID: 3733378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study.
    Armstrong DK; Blessing JA; Rader J; Sorosky JI;
    Invest New Drugs; 2003 Nov; 21(4):453-7. PubMed ID: 14586213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH; Blessing JA; Homesley HD
    Am J Clin Oncol; 1995 Dec; 18(6):495-7. PubMed ID: 8526192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
    Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
    Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
    Muss HB; Sutton GP; Bundy B; Hatch KD
    Am J Clin Oncol; 1985 Aug; 8(4):312-5. PubMed ID: 3909803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; McGuire WP; Patton T; Look KY
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies. A Southwest Oncology Group study.
    Taylor SA; Crowley J; Townsend J; Vogel FS; Eyre H; Braun JJ; Goodwin JW
    J Neurooncol; 1993 Feb; 15(2):181-4. PubMed ID: 8509822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; McGehee R; Barrett RJ
    J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; Rettenmaier M; Ball H
    Invest New Drugs; 1989 Nov; 7(4):337-40. PubMed ID: 2599803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
    Garcia AA; Blessing JA; Darcy KM; Lenz HJ; Zhang W; Hannigan E; Moore DH
    Gynecol Oncol; 2007 Mar; 104(3):572-9. PubMed ID: 17049588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barrett RJ; Gallup DG
    Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II trial of merbarone (NSC 336628) as salvage therapy for squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Look KY; Blessing JA; Williams L; Morris M
    Am J Clin Oncol; 1995 Oct; 18(5):441-3. PubMed ID: 7572765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Bundy BN; Given FT; Stehman FB
    Am J Clin Oncol; 1990 Apr; 13(2):117-8. PubMed ID: 2316480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.